Home › Companies › PACIFIC BIOSCIENCES OF CALIFORNIA INC. › 2023-2024

PACIFIC BIOSCIENCES OF CALIFORNIA INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed 2024-06-20 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 234Asset managers
  • 2,115Fund votes
  • 2024-06-18Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PACIFIC BIOSCIENCES OF CALIFORNIA INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC.

These tallies are PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIFIC BIOSCIENCES OF CALIFORNIA INC. — official shareholder meeting results, meeting held 2024-06-18
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Randy Livingston 148,986,27214,661,085467,711 --39,362,937 Majority: yes
Elect Director: David Meline 162,144,8691,502,258467,941 --39,362,937 Majority: yes
Elect Director: Marshall Mohr 144,558,38219,055,246501,440 --39,362,937 Majority: yes
Elect Director: Hannah A. Valantine, M.D. 161,569,2092,101,918443,941 --39,362,937 Majority: yes
Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm 200,217,2372,290,771969,997 ---- Majority: yes
Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation 156,288,3996,887,156939,513 --39,362,937 Majority: yes
Proposal 4: Approval of an Increase to the Number of Shares of Common Stock Authorized for Issuance Under the 2020 Equity Incentive Plan 121,356,66341,898,120860,285 --39,362,937 Majority: yes
Proposal 5: Amendment to the Certificate of Incorporation to Declassify the Board of Directors 161,566,2491,850,836697,983 --39,362,937 Majority: yes
Proposal 6: Amendment to the Certificate of Incorporation to Limit the Liability of Officers as Permitted by Delaware Law 143,620,30519,561,584933,179 --39,362,937 Majority: yes

Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC., Form 8-K, filed with the SEC on 2024-06-20 — read the filing on EDGAR.

How asset managers voted at the PACIFIC BIOSCIENCES OF CALIFORNIA INC. 2023-2024 meeting

Each item below shows how the 234 asset managers that disclosed a PACIFIC BIOSCIENCES OF CALIFORNIA INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 156,288,399AGAINST: 6,887,156

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation”): 156,288,399 for, 6,887,156 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 57% for, 3% against (60% of the company cast a for/against vote).

The 230 asset managers below cast 98% of the shares they voted on this item FOR (133,781,264 for, 2,876,852 against).

FOR 98%
FOR: 133,781,264 (97.8%)AGAINST: 2,876,852 (2.1%)ABSTAIN: 107,557 (0.1%)NOT VOTED: 86 (0.0%)
Largest asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,939,6800 00For
Madrone Advisors, LLC17,591,9150 00For
Nikko Asset Management Americas, Inc.11,970,3830 00For
EDMOND DE ROTHSCHILD HOLDING S.A.11,655,4040 00For
Capital Group11,452,6570 00For
Newton Investment Management North America, LLC7,523,0970 00For
BNY Mellon5,663,189251,982 00For
BlackRock5,515,832104,996 00For
Jackson Square Partners, LLC5,319,8720 00For
Charles Schwab3,997,6400 00For
State Street3,919,9680 00For
T. Rowe Price3,342,1100 00For
Deep Track Capital, LP1,818,9120 00For
Managed Portfolio Series1,680,3270 00For
Northern Trust1,307,83318,038 00For
DE Shaw972,9300 00For
MARSHALL WACE, LLP920,3800 00For
Dimensional0910,416 00Against
Nikko Asset Management Co., Ltd.848,6760 00For
HHLR ADVISORS, LTD.839,7940 00For
Citadel827,6650 00For
Vestmark Advisory Solutions, Inc.749,5140 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For

Showing the 25 largest of 230 asset managers. See all 230 in the interactive database.

2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 200,217,237AGAINST: 2,290,771

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm”): 200,217,237 for, 2,290,771 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 74% for, 0.9% against (74% of the company cast a for/against vote).

The 56 asset managers below cast 100% of the shares they voted on this item FOR (47,343,448 for, 0 against).

FOR 99.9%
FOR: 47,343,448 (99.9%)ABSTAIN: 41,546 (0.1%)
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the ye” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Investment Managers Series Trust II152,7470 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust98,7070 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

3. Election of Directors: David Meline

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 162,144,869AGAINST: 1,502,258

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: David Meline”): 162,144,869 for, 1,502,258 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 60% for, 0.6% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 100% of the shares they voted on this item FOR (47,186,857 for, 0 against).

FOR 99.9%
FOR: 47,186,857 (99.9%)ABSTAIN: 45,390 (0.1%)
Largest asset managers voting on “Election of Directors: David Meline” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust98,7070 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

4. Election of Directors: Hannah A. Valantine, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 161,569,209AGAINST: 2,101,918

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Hannah A. Valantine, M.D.”): 161,569,209 for, 2,101,918 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 59% for, 0.8% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 99.8% of the shares they voted on this item FOR (47,104,943 for, 81,914 against).

FOR 99.7%
FOR: 47,104,943 (99.7%)AGAINST: 81,914 (0.2%)ABSTAIN: 45,390 (0.1%)
Largest asset managers voting on “Election of Directors: Hannah A. Valantine, M.D.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust98,7070 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

5. Election of Directors: Marshall Mohr

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 144,558,382AGAINST: 19,055,246

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Marshall Mohr”): 144,558,382 for, 19,055,246 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 53.1% for, 7% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 94% of the shares they voted on this item FOR (44,416,105 for, 2,770,752 against).

FOR 94%
FOR: 44,416,105 (94.0%)AGAINST: 2,770,752 (5.9%)ABSTAIN: 45,390 (0.1%)
Largest asset managers voting on “Election of Directors: Marshall Mohr” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab01,998,620 00Against
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X0692,050 00Against
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust70,98227,725 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

6. Election of Directors: Randy Livingston

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 148,986,272AGAINST: 14,661,085

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Randy Livingston”): 148,986,272 for, 14,661,085 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 54.7% for, 5% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 99.7% of the shares they voted on this item FOR (47,077,218 for, 109,639 against).

FOR 99.6%
FOR: 47,077,218 (99.7%)AGAINST: 109,639 (0.2%)ABSTAIN: 45,390 (0.1%)
Largest asset managers voting on “Election of Directors: Randy Livingston” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust70,98227,725 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

7. To approve an amendment to our certificate of incorporation to declassify our board of directors.

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 161,566,249AGAINST: 1,850,836

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 5: Amendment to the Certificate of Incorporation to Declassify the Board of Directors”): 161,566,249 for, 1,850,836 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 59% for, 0.7% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 100% of the shares they voted on this item FOR (47,232,247 for, 0 against).

FOR 100%
FOR: 47,232,247 (100.0%)
Largest asset managers voting on “To approve an amendment to our certificate of incorporation to declassify our board of directors.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust98,7070 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

8. To approve an amendment to our certificate of incorporation to limit the liability of officers as permitted by law.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 143,620,305AGAINST: 19,561,584

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 6: Amendment to the Certificate of Incorporation to Limit the Liability of Officers as Permitted by Delaware Law”): 143,620,305 for, 19,561,584 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 52.7% for, 7% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 98% of the shares they voted on this item FOR (46,264,561 for, 926,140 against).

FOR 98%
FOR: 46,264,561 (98.0%)AGAINST: 926,140 (2.0%)ABSTAIN: 41,546 (0.1%)
Largest asset managers voting on “To approve an amendment to our certificate of incorporation to limit the liability of officers as permitted by” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,3560 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series1,680,3270 00For
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X0692,050 00Against
Dimensional566,0350 00For
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial226,5650 00For
John Hancock167,1810 00For
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli100,0000 00For
Bridge Builder Trust70,98227,725 00For
Pacific Life91,3730 00For
JPMorgan084,725 00Against
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya82,4450 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

9. To approve one or more adjournments of the meeting from time to time, if necessary or appropriate (as determined by our board of directors or the chairperson of the meeting), including to solicit additional proxies to vote in favor of any of Proposals 1-6 above in the event that there are insufficient votes at the time of the meeting to establish a quorum or approve any of Proposals 1-6 above.

CORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

89% fund support · no official result

FOR 89%11%

The 55 asset managers below cast 89% of the shares they voted on this item FOR (42,227,321 for, 4,963,380 against).

FOR: 42,227,321 (89.4%)AGAINST: 4,963,380 (10.5%)ABSTAIN: 41,546 (0.1%)
Largest asset managers voting on “To approve one or more adjournments of the meeting from time to time, if necessary or appropriate (as determin” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,189167 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series01,680,327 00Against
T. Rowe Price01,360,909 00Against
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional0566,035 00Against
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable513,7623,892 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA0270,184 00Against
Lincoln Financial0226,565 00Against
John Hancock0167,181 00Against
Federated Hermes126,7470 00For
EntrepreneurShares Series Trust112,5670 00For
Northern Trust0110,258 00Against
Gabelli100,0000 00For
Bridge Builder Trust70,98227,725 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya082,445 00Against

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

10. To approve the amendment of our 2020 Equity Incentive Plan.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST 26%
FOR: 121,356,663AGAINST: 41,898,120

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Proposal 4: Approval of an Increase to the Number of Shares of Common Stock Authorized for Issuance Under the 2020 Equity Incentive Plan”): 121,356,663 for, 41,898,120 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 272,280,000 outstanding shares: 45% for, 15% against (60% of the company cast a for/against vote).

The 55 asset managers below cast 93% of the shares they voted on this item FOR (44,022,140 for, 3,168,561 against).

FOR 93%
FOR: 44,022,140 (93.2%)AGAINST: 3,168,561 (6.7%)ABSTAIN: 41,546 (0.1%)
Largest asset managers voting on “To approve the amendment of our 2020 Equity Incentive Plan.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard24,485,6780 00For
Capital Group5,726,2490 00For
BNY Mellon5,663,189167 00For
Charles Schwab1,998,6200 00For
Managed Portfolio Series01,680,327 00Against
T. Rowe Price1,360,9090 00For
AMERICAN BEACON FUNDS712,7140 00For
Global X692,0500 00For
Dimensional0566,035 00Against
BOURNE LENT ASSET MANAGEMENT INC553,7150 00For
Equitable517,6540 00For
BlackRock514,1400 00For
Fidelity459,9650 00For
TIAA270,1840 00For
Lincoln Financial211,29815,267 00For
John Hancock73,41193,770 00Against
Federated Hermes0126,747 00Against
EntrepreneurShares Series Trust112,5670 00For
Northern Trust110,2580 00For
Gabelli0100,000 00Against
Bridge Builder Trust70,98227,725 00For
Pacific Life91,3730 00For
JPMorgan84,7250 00For
MASTER INVESTMENT PORTFOLIO84,6420 00For
Voya082,445 00Against

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

Largest PACIFIC BIOSCIENCES OF CALIFORNIA INC. shareholders voting in 2023-2024

Ranked by the number of PACIFIC BIOSCIENCES OF CALIFORNIA INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 272,280,000 shares outstanding at the time of that meeting.

Top PACIFIC BIOSCIENCES OF CALIFORNIA INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.16%
2Madrone Advisors, LLC 6.46%
3Nikko Asset Management Americas, Inc. 4.40%
4EDMOND DE ROTHSCHILD HOLDING S.A. 4.28%
5Capital Group 4.21%
6Newton Investment Management North America, LLC 2.76%
7BNY Mellon 2.17%
8BlackRock 2.06%
9Jackson Square Partners, LLC 1.95%
10Charles Schwab 1.47%

Reported PACIFIC BIOSCIENCES OF CALIFORNIA INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

PACIFIC BIOSCIENCES OF CALIFORNIA INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
ARK Investment Management LLC 12.67% DEF14A
BlackRock 8.34% 13F
Madrone Opportunity Fund, L.P. 6.46% DEF14A
Vanguard Group 6.02% 13F
BNY Mellon 4.18% 13F
Jackson Square Partners, LLC 3.56% 13G
State Street 2.12% 13F
Geode Capital 2.07% 13F
Dimensional Fund Advisors 1.26% 13F
Capital International 1.14% 13F

Percentages above are of 272,280,000 shares outstanding, as reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s shareholder meeting held 2024-06-18, in the 2023-2024 proxy season, 234 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,115 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-20.

PACIFIC BIOSCIENCES OF CALIFORNIA INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.